Bernard Klein

22.2k total citations · 1 hit paper
390 papers, 17.4k citations indexed

About

Bernard Klein is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Bernard Klein has authored 390 papers receiving a total of 17.4k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Hematology, 143 papers in Molecular Biology and 109 papers in Oncology. Recurrent topics in Bernard Klein's work include Multiple Myeloma Research and Treatments (156 papers), Immunotherapy and Immune Responses (47 papers) and Monoclonal and Polyclonal Antibodies Research (46 papers). Bernard Klein is often cited by papers focused on Multiple Myeloma Research and Treatments (156 papers), Immunotherapy and Immune Responses (47 papers) and Monoclonal and Polyclonal Antibodies Research (46 papers). Bernard Klein collaborates with scholars based in France, Germany and United States. Bernard Klein's co-authors include Régis Bataille, John De Vos, M Jourdan, Jean‐François Rossi, Jérôme Moreaux, Michel Jourdan, Thierry Rème, Dirk Hose, Karin Tarte and XG Zhang and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Bernard Klein

378 papers receiving 16.7k citations

Hit Papers

Paracrine rather than aut... 1989 2026 2001 2013 1989 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bernard Klein 7.4k 6.6k 6.4k 4.8k 1.7k 390 17.4k
Jordan U. Gutterman 4.8k 0.7× 4.0k 0.6× 5.4k 0.8× 4.5k 0.9× 1.8k 1.1× 312 16.2k
Edo Vellenga 7.6k 1.0× 8.7k 1.3× 5.3k 0.8× 3.4k 0.7× 1.3k 0.8× 487 18.7k
Fumimaro Takaku 8.8k 1.2× 3.1k 0.5× 3.3k 0.5× 4.3k 0.9× 800 0.5× 657 20.9k
James D. Griffin 12.8k 1.7× 12.4k 1.9× 7.4k 1.2× 5.3k 1.1× 1.7k 1.0× 354 29.7k
John H. Kersey 3.7k 0.5× 4.4k 0.7× 2.6k 0.4× 3.4k 0.7× 1.3k 0.8× 207 12.8k
Bernd Dörken 8.6k 1.2× 3.0k 0.5× 8.6k 1.4× 5.0k 1.0× 4.8k 2.8× 412 22.0k
Richard J. Jones 3.3k 0.5× 7.8k 1.2× 4.3k 0.7× 3.8k 0.8× 1.8k 1.1× 333 14.4k
Olivier Bernard 8.7k 1.2× 5.2k 0.8× 4.0k 0.6× 2.2k 0.5× 1.2k 0.7× 448 21.9k
Ugo Testa 8.7k 1.2× 4.9k 0.7× 3.0k 0.5× 3.7k 0.8× 631 0.4× 423 16.9k
Meinrad Gawaz 5.5k 0.7× 6.4k 1.0× 3.2k 0.5× 4.2k 0.9× 705 0.4× 607 26.7k

Countries citing papers authored by Bernard Klein

Since Specialization
Citations

This map shows the geographic impact of Bernard Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Klein more than expected).

Fields of papers citing papers by Bernard Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Klein. The network helps show where Bernard Klein may publish in the future.

Co-authorship network of co-authors of Bernard Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Klein. A scholar is included among the top collaborators of Bernard Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Klein. Bernard Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gourzonès, Claire, Céline Bellanger, Sylvain Lamure, et al.. (2019). Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells. Cancers. 11(4). 439–439. 26 indexed citations
2.
Moreaux, Jérôme, Thierry Rème, Jean‐Luc Veyrune, et al.. (2012). Development of Gene Expression–Based Score to Predict Sensitivity of Multiple Myeloma Cells to DNA Methylation Inhibitors. Molecular Cancer Therapeutics. 11(12). 2685–2692. 39 indexed citations
3.
Corre, Jill, Nicolas Espagnolle, Benjamin Hébraud, et al.. (2012). Bioactivity and Prognostic Significance of Growth Differentiation Factor GDF15 Secreted by Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma. Cancer Research. 72(6). 1395–1406. 76 indexed citations
4.
Witzens‐Harig, Mathias, Philipp Beckhove, Dirk Hose, et al.. (2012). Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma. Experimental Hematology. 41(3). 231–240. 6 indexed citations
5.
Meißner, Tobias, Anja Seckinger, Thierry Rème, et al.. (2011). Gene Expression Profiling in Multiple Myeloma—Reporting of Entities, Risk, and Targets in Clinical Routine. Clinical Cancer Research. 17(23). 7240–7247. 30 indexed citations
6.
Hose, Dirk, Jérôme Moreaux, Brian A. Walker, et al.. (2011). Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma. Haematologica. 97(4). 622–630. 41 indexed citations
7.
Assou, Saïd, Sylvie Tondeur, Ludovic Lhermitte, et al.. (2010). Amazonia!: An Online Resource to Google and Visualize Public Human whole Genome Expression Data. 4(1). 5–10. 49 indexed citations
8.
Braza, Mounia S., Bernard Klein, Geneviève Fiol, & Jean François Rossi. (2010).    T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody. Haematologica. 96(3). 400–407. 59 indexed citations
9.
Jourdan, Michel, Thierry Rème, Hartmut Goldschmidt, et al.. (2009). Gene expression of anti‐ and pro‐apoptotic proteins in malignant and normal plasma cells. British Journal of Haematology. 145(1). 45–58. 61 indexed citations
10.
Bret, Caroline, Dirk Hose, Thierry Rème, et al.. (2009). Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells. British Journal of Haematology. 145(3). 350–368. 53 indexed citations
11.
Condomines, Maud, Jean‐Luc Veyrune, Marion Larroque, et al.. (2009). Increased Plasma-Immune Cytokines throughout the High-Dose Melphalan-Induced Lymphodepletion in Patients with Multiple Myeloma: A Window for Adoptive Immunotherapy. The Journal of Immunology. 184(2). 1079–1084. 33 indexed citations
12.
Condomines, Maud, Dirk Hose, Thierry Rème, et al.. (2009). Gene Expression Profiling and Real-Time PCR Analyses Identify Novel Potential Cancer-Testis Antigens in Multiple Myeloma. The Journal of Immunology. 183(2). 832–840. 26 indexed citations
13.
Braza, Mounia S., Anouk Caraux, Thérèse Rousset, et al.. (2009). γδ T Lymphocytes Count Is Normal and Expandable in Peripheral Blood of Patients with Follicular Lymphoma, Whereas It Is Decreased in Tumor Lymph Nodes Compared with Inflammatory Lymph Nodes. The Journal of Immunology. 184(1). 134–140. 15 indexed citations
14.
Condomines, Maud, Philippe Quittet, Zhao‐Yang Lu, et al.. (2006). Functional Regulatory T Cells Are Collected in Stem Cell Autografts by Mobilization with High-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor. The Journal of Immunology. 176(11). 6631–6639. 47 indexed citations
15.
Rème, Thierry, et al.. (2001). Growth and immortalization of human myeloma cells in immunodeficient severe combined immunodeficiency mice: a preclinical model. British Journal of Haematology. 114(2). 406–413. 11 indexed citations
17.
Harousseau, J. L. & Bernard Klein. (1996). Utilisation de l'interféron alpha dans le myélome multiple. La Revue de Médecine Interne. 17(6). 488–495. 2 indexed citations
19.
Montero‐Julian, Félix A., Emmanuel Gautherot, John Wijdenes, Bernard Klein, & Hervé Brailly. (1994). Pharmacokinetics of Interleukin-6 During Therapy with Anti-Interleukin-6 Monoclonal Antibodies: Enhanced Clearance of Interleukin-6 by a Combination of Three Anti-Interleukin-6 Antibodies. Journal of Interferon Research. 14(5). 301–302. 19 indexed citations
20.
Klein, Bernard, et al.. (1990). Interleukin-6 is a Major Myeloma Cell Growth Factor In Vitro and In Vivo Especially in Patients with Terminal Disease. Current topics in microbiology and immunology. 166. 23–31. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026